New Executive Committee Members Named to CTTI Posted on May 7, 2013July 21, 2021 by Hannah Faulkner New Executive Committee Members Named to CTTI
Participants’ Perspectives on Safety Monitoring in Clinical Trials Posted on May 3, 2013February 11, 2025 by Hannah Faulkner Participants’ Perspectives on Safety Monitoring in Clinical Trials
Cancer Studies Often Lack Necessary Rigor to Answer Key Questions Posted on April 30, 2013February 17, 2025 by Hannah Faulkner Cancer Studies Often Lack Necessary Rigor to Answer Key Questions
Characteristics of Oncology Clinical Trials: Insights from a Systematic Analysis of ClinicalTrials.gov Posted on April 29, 2013February 17, 2025 by Hannah Faulkner Characteristics of Oncology Clinical Trials: Insights from a Systematic Analysis of ClinicalTrials.gov
Treatments, Not Prevention, Dominate Diabetes Research Posted on April 8, 2013February 17, 2025 by Hannah Faulkner Treatments, Not Prevention, Dominate Diabetes Research
Are current clinical trials in diabetes addressing important issues in diabetes care? Posted on February 26, 2013February 17, 2025 by Hannah Faulkner Are current clinical trials in diabetes addressing important issues in diabetes care?
CTTI Forms Patient Leadership Council to Help Drive Improvements in Clinical Trials Posted on February 15, 2013July 21, 2021 by Hannah Faulkner CTTI Forms Patient Leadership Council to Help Drive Improvements in Clinical Trials
Using Central IRBs for Multicenter Clinical Trials in the United States Posted on January 30, 2013February 11, 2025 by Hannah Faulkner Using Central IRBs for Multicenter Clinical Trials in the United States
Conducting Multi-Center Trials: New Recommendations and Tool for Research Posted on January 30, 2013February 11, 2025 by Hannah Faulkner Conducting Multi-Center Trials: New Recommendations and Tool for Research
Cycle Time Metrics for Multisite Clinical Trials in the United States Posted on January 4, 2013February 20, 2025 by Hannah Faulkner Cycle Time Metrics for Multisite Clinical Trials in the United States
